Showing results (321-330 of 1,142) with videos related to
Sort By:
Pageof 115
Pathogens (Basel, Switzerland)|June 2, 2021
Pharmacotherapy Profiles in People with Opioid Use Disorders: Considerations for Relevant Drug-Drug Interactions with Antiviral Treatments for Hepatitis CAndreas Hintz, Tim Umland, Gero Niess, et al.Journal of Hepatology|June 24, 2022
Immune mechanisms linking metabolic injury to inflammation and fibrosis in fatty liver disease - novel insights into cellular communication circuitsMoritz Peiseler, Robert Schwabe, Jochen Hampe, et al.Journal of Immunology (Baltimore, Md. : 1950)|March 7, 2006
Modulation of dendritic cell trafficking to and from the airwaysClaudia Jakubzick, Frank Tacke, Jaime Llodra, et al.Journal of Critical Care|September 28, 2010
Serum adiponectin upon admission to the intensive care unit may predict mortality in critically ill patientsAlexander Koch, Edouard Sanson, Sebastian Voigt, et al.Journal of Virology|November 6, 2009
Differential impact of immune escape mutations G145R and P120T on the replication of lamivudine-resistant hepatitis B virus e antigen-positive and -negative strainsSamad Amini-Bavil-Olyaee, Mihael Vucur, Tom Luedde, et al.Methods in Molecular Biology (Clifton, N.J.)|August 25, 2017
Isolation and Culture of Primary Murine Hepatic Stellate CellsSabine Weiskirchen, Carmen G Tag, Sibille Sauer-Lehnen, et al.Critical Care (London, England)|May 27, 2010
Regulation and prognostic relevance of serum ghrelin concentrations in critical illness and sepsisAlexander Koch, Edouard Sanson, Anita Helm, et al.AIDS (London, England)|December 23, 2008
Molecular analysis of an HBsAg-negative hepatitis B virus mutant selected in a tenofovir-treated HIV-hepatitis B virus co-infected patientSamad Amini-Bavil-Olyaee, Julie Sheldon, Thomas Lutz, et al.Cytometry. Part B, Clinical Cytometry|May 20, 2023
Resolving 31 colors on a standard 3-laser full spectrum flow cytometer for immune monitoring of human blood samplesLinda Hammerich, Yaroslava Shevchenko, Jana Knorr, et al.Cancer Cell International|June 20, 2024
CDK4/6 inhibition enhances T-cell immunotherapy on hepatocellular carcinoma cells by rejuvenating immunogenicityXiurong Cai, Guo Yin, Shuai Chen, et al.Pageof 115